ARTICLE | Clinical News
Vidaza azacitidine regulatory update
October 27, 2008 7:00 AM UTC
EMEA's CHMP recommended approval for Vidaza to treat myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myelogenous leukemia (AML) in adult patients who are not eligible...